It’s a great news for Brittany biotechnologies domain. Biotrial opens a new site in USA to grow up its capacity for phase 1 studies. The Newark site will perform up to 50 studies per year ! Congratulation Biotrial.

According to Francois Peaucelle, General Manager, Biotrial, the company has started activities with studies for European and American biotech, the pharma industry, and US generics companies.

Source: Biotrial: transparency key as CRO moves forward in US


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

Leave a Reply